THC vs CBD vs CBG vs CBN vs THCV: The Real Differences Explained
THC vs CBD vs CBG vs CBN vs THCV explains how each cannabinoid targets different receptors and produces distinct clinical effects. Dr. Benjamin Caplan breaks down the evidence behind pain, sleep, focus, and metabolic use cases for each compound. This…
Lesser-known cannabis compounds show promise for treating alcohol addiction in rats
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthNeurologyCBNTHCVAddictionAlcohol Why This Matters Clinicians treating patients with alcohol use…
Effect of cannabinol, tetrahydrocannabivarin and cannabidiol on voluntary alcohol consumption.
Previous studies have demonstrated that the endocannabinoid system plays a significant role in the development of alcohol use disorder (AUD), and CB1 recepto...
BudPop Delta-9 + CBN Gummies Ranked #1 as Cannabis Sleep Aids Outperform Traditional Pills
Cannabis sleep aids, including Delta-9 + CBN gummies, are gaining attention for sleep disorder management. This page reviews their clinical relevance and marketing claims. Patients and clinicians should evaluate these aids carefully for evidence-based…
Cannabinoids for Sleep: Could Cannabinol Be the Best Option? – Study Summary
Cannabinoid sleep research 2026 highlights emerging evidence on cannabinol as a potential sleep aid. This research adds to our understanding of cannabinoid-specific effects on insomnia. While promising, clinical data remain limited, warranting further…
FloraWorks Announces TruCBN(TM) Readiness for CMS Substance Access Program
The CBN cannabinoid safety profile is advancing with FloraWorks' TruCBN readiness for CMS Substance Access. Clinical trial data show adverse events comparable to placebo, supporting safety. This progress may improve patient access to regulated…
FloraWorks Announces TruCBN(TM) Readiness for CMS Substance Access Program
FloraWorks has announced TruCBN(TM) readiness for CMS Substance Access, highlighting CBN clinical validation pathways. This development signals potential regulatory progress for cannabinoid products. Clinicians should monitor emerging evidence on CBN…
CBN Slices Interest Rates On 182, 364-Day Treasury Bills – MarketForces Africa
This article covers the CBN monetary policy treasury bills interest rate adjustments on 182 and 364-day bills. It clarifies that the CBN here refers to the Central Bank of Nigeria, not cannabinol. Understanding these changes is important for those…
Study: CBN and THCV Effective in Reducing Alcohol Intake, Outperforming CBD
Cannabinoids alcohol use disorder research highlights the potential of CBN and THCV in reducing alcohol consumption. These cannabinoids outperform CBD in preclinical models. Further human trials are needed to confirm these findings.
Beyond Licensing: The New Face of Fintech Compliance Under NDPA, GAID, and CBN
This article covers fintech compliance Nigeria focusing on NDPA, GAID, and CBN regulatory frameworks. It highlights emerging compliance requirements for fintech licensing. Healthcare providers should note this is non-clinical content unrelated to…